Description: Are you searching for an overview of the SOA Research Institute's Mortality & Longevity Strategic Research Program? Join us for an introduction into studies focusing on the historical U.S. population and insured mortality trends. Two research projects are observed in this webcast, one examining the impact of COVID-19 on mental illness and the impact of mental illness on U.S. Mortality & Longevity. The second study looks into the Group Life COVID-19 Mortality Survey and the high level view of U.S. group term life insurance mortality results during the pandemic. Come explore the research goals and the future for the Mortality & Longevity Strategic Program.

Description: Planning for retirement is at the top of many minds. How do I save? When is the right time? What are my plans? But what are the impacts of your health on retirement? Learn more about the effects of a healthy lifestyle on retirement in order to maximize life span. Review more in-depth findings from a recent report sponsored by the SOA Research Institute’s Aging and Retirement Strategic Research Program and conducted by the Vitality Group, as well as other expert insights.

Description: Since its inception, the SOA Research Institute's Mortality and Longevity Strategic Research Program has introduced studies to provide insights into historical U.S. population mortality trends. Learn more about a recent focus that examines how causes of death are affecting trends. Come discover an overview of the research underway and discuss the latest findings including how causes of death are contributing to socioeconomic inequalities in U.S. mortality.

Description: Insurance companies are substantially transforming their finance operating model. This is mainly trigged by the prevailing changes in the insurance regulatory landscape that are leaning towards principle-based reporting and valuation, which is leading to a significant increase in the effort needed for regulatory and management reporting.

Description: Join the IAJ (the Institute of Actuaries of Japan) as they deep dive the Japan mortality and morbidity trend impacted by COVID-19. During COVID-19, Japan experienced increasing COVID-19 patients and deteriorated morbidity trend mainly due to deemed hospitalization. This was introduced to regard the treatment under the doctors' supervision outside of the hospital as hospitalization, given shortage of hospital beds, and add accident death benefit payment triggered by COVID-19. Expect coverage on the mortality/morbidity analysis comparison in Japan, US and globally, as well as comprehensively discuss how Japanese insurers identified solutions to respond to the changing market. Also, you'll discuss consumers' needs and how more uncertainty drives them to prepare individual lifetime retirement income.

Description: Mortality improvement for the U.S. general population has stagnated in recent years and then further deteriorated with the COVID-19 pandemic. However, mortality improvement by socioeconomic factors such as education and income has varied widely during this time period. Explore with us cause-of-death mortality rate trends as well as overall mortality improvement trends by different socioeconomic factors. Join a discussion on approaches that companies can take to proxy the insured population by applying socioeconomic factors to the general population with the goal of better understanding future mortality trends for the insured population.

Description: Since its inception, the Society of Actuaries (SOA) Research Institute's Mortality and Longevity Strategic Research Program has introduced studies to provide insights into historical and future U.S. population mortality trends. Learn about the recent focus to understand the growing mortality differences in the U.S. Come discover an overview of the research underway. Discuss the latest findings including how COVID-19 has impacted socioeconomic inequalities in U.S. mortality as well as how health status contributes to U.S. mortality.

Description: This session will bring together public health care leaders in COVID-10 vaccine delivery from both the U.S. and the UK to discuss and compare operational implications of the COVID-19 vaccine rollout in their countries, and how those programs ultimately affected hospitalization utilization and mortality rates for members of their communities.

Description: The United Kingdom makes public an impressive body of data about its population, its health system (the NHS), and the care which the NHS provides to the nation. This session will take the audience on a tour of many of these sets - with a focus on uncovering healthcare disparities. For context, a brief description of the NHS in England, population characteristics of England, and how social determinants of health (SDOH) are quantified will be given. With these as a background, we will explore data on chronic disease prevalence and incidence as well as physician performance against targets. We will present examples of health disparities from this data for certain conditions. Datasets of UK prescribing will be shown for further detail. The closing portion of this talk will present similar public domain US data - and how the UK body of information can assist in understanding health disparities in the US.

Description: As we entered 2014, actuaries became familiar with three risk stabilizing mechanisms in the early years of the ACA marketplaces, colloquially known as 'the 3Rs'. As we enter 2024, there is renewed focus on rating compliance and risk adjustment. Speakers will highlight pricing considerations when determining cost-sharing reduction premium loads as well as related issues pertaining to risk adjustment and metal tier pricing.